<DOC>
	<DOCNO>NCT02191462</DOCNO>
	<brief_summary>The purpose study analyse way body process Niagen ( nicotinamide riboside ) healthy people . Blood urine sample subject give dose Niagen analyze metabolite 24 hour take dose .</brief_summary>
	<brief_title>A Study Pharmacokinetics Three Dosages Niagen Healthy Subjects</brief_title>
	<detailed_description />
	<criteria>Healthy Male female age 3055 year BMI 18.529.9 kg/m2 If female , subject child bear potential , OR Females childbearing potential must agree use medically approve method birth control negative urine pregnancy test result . Healthy determine laboratory result medical history Agrees maintain current level physical activity throughout study Agrees avoid vitamins St. John 's Wort 30 day prior enrollment study Agrees avoid nutritional yeast , whey protein , energy drink , dairy product , grapefruit grapefruit juice alcohol 7 day prior enrollment study Has give voluntary , write , inform consent participate study Women pregnant , breastfeeding , plan become pregnant course trial . Use natural health product ( NHPs ) /dietary supplement within 7 day prior randomization course study . Use vitamins St. John 's Wort last 30 day study enrollment , Use natural health product contain Nicotinamide riboside within 7 day prior randomization course study Use nutritional yeast , whey protein , energy drink , grapefruit grapefruit juice , dairy product , alcohol 7 day prior study Subjects smoker Subjects blood pressure â‰¥140/90 Use blood pressure medication Use cholesterol lower medication Metabolic diseases chronic disease Use acute counter medication within 72 hour test product dose Unstable medical condition determine Qualified Investigator Immunocompromised individual subject undergo organ transplantation subject diagnose human immunodeficiency virus ( HIV ) Clinically significant abnormal lab result screen ( e.g . AST and/or ALT &gt; 2 x ULN , and/or bilirubin &gt; 2 x ULN ) assess Medical Investigator Subjects plan surgery course trial History current diagnosis cancer ( except successfully treat basal cell carcinoma ) diagnose less 5 year prior screen . Subjects cancer full remission 5 year diagnosis acceptable History blood/bleeding disorder Blood donation past 2 month Alcohol abuse ( &gt; 2 standard alcoholic drink per day ) drug abuse within past 6 month Participation clinical research trial within 30 day prior randomization Allergy sensitivity study supplement ingredient food beverage provide study Individuals cognitively impair and/or unable give inform consent . Any condition Investigator 's opinion may adversely affect subject 's ability complete study measure may pose significant risk subject</criteria>
	<gender>All</gender>
	<minimum_age>30 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>September 2014</verification_date>
	<keyword>Pharmacokinetics</keyword>
	<keyword>Niagen</keyword>
	<keyword>Nicotinamide riboside</keyword>
</DOC>